Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro

dc.contributor.author	Caglar Esber
dc.contributor.author	Gorgulu Mehmet
dc.contributor.author	Kuscu Ozgur.
dc.date.accessioned	2019-07-10T13:30:22Z
dc.date.available	2019-07-10T13:30:22Z
dc.date.issued	2016
dc.identifier.uri	http://hdl.handle.net/11547/3187
dc.publisher	NEUROLOGICAL RESEARCH
dc.title	Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro
dc.publisher.volume	38
dc.publisher.issue	9
dc.publisher.firstpagenumber	766
dc.publisher.lastpagenumber	774
dc.identifier.doinumber	10.1080/01616412.2016.1203096
dc.identifier.wos	WOS:000384284900003